# BridgeBio Pharma, Inc.: Form 8-K, filed Apr 29, 2025

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: 8-K
- Filed: 2025-04-29
- Accepted by EDGAR: Apr 29, 2025, 16:04 ET
- Period: 2025-04-29
- Accession: 0000950170-25-060085
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000095017025060085/bbio-20250429.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000095017025060085/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000095017025060085/bbio-20250429.htm

Filed Apr 29, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-060085. Last ingested by Listed: Oct 29, 2026, 19:20 ET. No prices; not investment advice.